Conestoga updates Transcat ownership in 13G filing
Conestoga Capital Advisors filed Amendment No. 5 to a Schedule 13G reporting its beneficial ownership of Transcat Inc. common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Conestoga Capital Advisors filed Amendment No. 5 to a Schedule 13G reporting its beneficial ownership of Transcat Inc. common stock. Conestoga Capital Advisors reports beneficial ownership of 1,013,365 shares, representing 10.86% of the outstanding common stock, with sole voting power over 943,437 shares and sole dispositive power over 1,013,365 shares. CONESTOGA FUNDS reports beneficial ownership of 626,699 shares, or 6.72% of the class, with sole voting and dispositive power over those shares. The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Transcat Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Schedule 13G/A filing disclose about Conestoga's stake in Transcat (TRNS)?
What voting and dispositive powers does Conestoga Capital Advisors report over Transcat (TRNS) shares?
Why was this Schedule 13G/A Amendment No. 5 filed for Transcat (TRNS)?
Is Conestoga seeking to influence control of Transcat (TRNS) through this ownership?
What type of reporting person is Conestoga Capital Advisors in this Transcat (TRNS) filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.